ARCHIVES

Jane Henney Said Tentative Choice For FDA Commissioner

This article is from The Cancer Letter archive.

Vol. 24 No. 20 | May 22, 1998

Download PDF Visit The Full Archive

Related Articles

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011